Sarah Cavanaugh, SVP of Corporate Affairs & Administration at Celldex Therapeutics, Inc. (CLDX), sold 13,745 shares at $41.62 ($595K) on 2021-11-01, disclosed to the SEC on 2021-11-03.
Open-market sale of $595k CLDX by SVP of Corporate Affairs & Administration. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.62 | 2,120 | $88K | 14.8% |
| 2 | $41.62 | 2,120 | $88K | 14.8% |
| 3 | $43.06 | 901 | $39K | 6.5% |
| 4 | $44.11 | 4,302 | $190K | 31.9% |
| 5 | $44.11 | 4,302 | $190K | 31.9% |
| Total | $43.27 avg | 13,745 |
| $595K |
| 100% |
| Filing → |
| CLDX | SELL | 2021-12-10 | $293K | — | Filing → |
| CLDX | BUY | 2020-06-11 | $5K | — | Filing → |